
Loading, please wait...

Loading, please wait...

The medical procurement scam in Chhattisgarh has seen significant developments recently. The state’s Anti-Corruption Bureau (ACB) and Economic Offence Wing (EOW) filed a supplementary chargesheet against four key individuals. These individuals allegedly facilitated irregularities in the procurement of medical equipment and reagents during 2023. Consequently, the state exchequer suffered massive financial losses.
Investigation results show that the accused collaborated to manipulate the tender process. Specifically, firms like Mokshit Corporation and Shri Sharda Industries fabricated documents to secure contracts. Furthermore, these companies quoted identical prices for various consumables. They intentionally inflated the prices of essential items, including EDTA tubes and CBC machines. For instance, Mokshit Corporation sold EDTA tubes at Rs 2,352 each, despite the standard market rate of Rs 8.50. This blatant overpricing caused a loss of approximately Rs 550 crore to the government. Additionally, the firms supplied CBC machines at nearly triple their market value.
The ACB/EOW named officials from several prominent medical supply companies in the latest filing. These include representatives from Recorders and Medicare Systems and DiaSys India. Moreover, the investigation found that the companies fixed high maximum retail prices to deceive the Chhattisgarh Medical Services Corporation (CGMSC). Although the original FIR did not name specific individuals, the supplementary chargesheet provides a clearer picture of the collusion. Authorities continue to examine the roles of health department officials in this multi-billion rupee scandal.
Q1: What was the primary cause of the financial loss in the medical procurement scam?
The financial loss stemmed from the supply of reagents and equipment at prices significantly higher than the actual market rates, sometimes reaching three times the normal cost.
Q2: Which institutions were involved in the procurement irregularities?
The Chhattisgarh Medical Services Corporation and the Directorate of Health Services were the primary government bodies involved in the procurement from the accused private firms.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Chhattisgarh ACB/EOW files a supplementary chargesheet against four individuals for a Rs 550 crore medical equipment procurement scam involving Mokshit Corp...
3 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today